UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
Too Old to Operate10h
Healthy Lifestyle Linked to Improved Retinal Health and Lower Inflammation
The following is a summary of “Associations between a healthy lifestyle score and retinal neurovascular health,” published in ...